AUTHOR=Johnson Kara A. , Dosenbach Nico U. F. , Gordon Evan M. , Welle Cristin G. , Wilkins Kevin B. , Bronte-Stewart Helen M. , Voon Valerie , Morishita Takashi , Sakai Yuki , Merner Amanda R. , Lázaro-Muñoz Gabriel , Williamson Theresa , Horn Andreas , Gilron Ro'ee , O'Keeffe Jonathan , Gittis Aryn H. , Neumann Wolf-Julian , Little Simon , Provenza Nicole R. , Sheth Sameer A. , Fasano Alfonso , Holt-Becker Abbey B. , Raike Robert S. , Moore Lisa , Pathak Yagna J. , Greene David , Marceglia Sara , Krinke Lothar , Tan Huiling , Bergman Hagai , Pötter-Nerger Monika , Sun Bomin , Cabrera Laura Y. , McIntyre Cameron C. , Harel Noam , Mayberg Helen S. , Krystal Andrew D. , Pouratian Nader , Starr Philip A. , Foote Kelly D. , Okun Michael S. , Wong Joshua K. TITLE=Proceedings of the 11th Annual Deep Brain Stimulation Think Tank: pushing the forefront of neuromodulation with functional network mapping, biomarkers for adaptive DBS, bioethical dilemmas, AI-guided neuromodulation, and translational advancements JOURNAL=Frontiers in Human Neuroscience VOLUME=18 YEAR=2024 URL=https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2024.1320806 DOI=10.3389/fnhum.2024.1320806 ISSN=1662-5161 ABSTRACT=

The Deep Brain Stimulation (DBS) Think Tank XI was held on August 9–11, 2023 in Gainesville, Florida with the theme of “Pushing the Forefront of Neuromodulation”. The keynote speaker was Dr. Nico Dosenbach from Washington University in St. Louis, Missouri. He presented his research recently published in Nature inn a collaboration with Dr. Evan Gordon to identify and characterize the somato-cognitive action network (SCAN), which has redefined the motor homunculus and has led to new hypotheses about the integrative networks underpinning therapeutic DBS. The DBS Think Tank was founded in 2012 and provides an open platform where clinicians, engineers, and researchers (from industry and academia) can freely discuss current and emerging DBS technologies, as well as logistical and ethical issues facing the field. The group estimated that globally more than 263,000 DBS devices have been implanted for neurological and neuropsychiatric disorders. This year's meeting was focused on advances in the following areas: cutting-edge translational neuromodulation, cutting-edge physiology, advances in neuromodulation from Europe and Asia, neuroethical dilemmas, artificial intelligence and computational modeling, time scales in DBS for mood disorders, and advances in future neuromodulation devices.